Economic burden of diabetes in Telangana: A Cost of illness study
The purpose of this study is to analyze the economic burden on people in Telangana due to diabetes. In Telangana, a prospective observational study was conducted by collecting patient data. 252 patient’s data was gathered in 6 months period. This data includes health care costs and complications that is both microvascular complications (Neuropathy, Retinopathy & Nephropathy) and macrovascular complications (Coronary heart disease, Congestive heart failure, Myocardial infarction & Peripheral artery disease). The collected data consists of direct and indirect costs which was analyzed & calculated average cost spent in the treatment of diabetic patients. All the type 2 diabetes mellitus patients who are on anti – diabetic drugs irrespective of their co- morbidities & gender were included. Patients who are not on regular medication were excluded from the study. In this study , cost of illness of type-2 diabetes mellitus patients with & without complications were compared. The total cost of treatment per annum in patients without complications was USD 374.77 & in patients with complications was USD 497.763.
2. American Diabetes Association. Classiﬁcation and diagnosis of diabetes: standards of medical care in diabetes - 2018. Diabetes Care 2018; 41[suppl 1]: S13e27.
3. Mayer-Davis EJ, Lawrence JM, Dabelea D, et al. SEARCH for Diabetes in Youth Study. Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012. N Engl J Med 2017; 376: 1419-29.
4. Sekikawa A, Tominaga M, Takahashi K, Eguchi H, Igarashi M, et al.  Prevalence of diabetes and impaired glucose tolerance in Funagata area, Japan. Diabetes Care 16: 570-574.
5. Ramachandran A, Snehalatha C, Latha E, Vijay V, Viswanathan M  Rising prevalence of NIDDM in an urban population in India. Diabetologia 40: 232-237.
6. Craig ME, Hattersley A, Donaghue KC  Definition, epidemiology and classification of diabetes in children and adolescents. Pediatr Diabetes 10 Suppl 12: 3-12.
7. Chaturvedi N. The burden of diabetes and its complications: Trends and implications for intervention. Diabetes Res Clin Pract. 2007; 76: S3–S12.
8. Jefferson T, Demicheli V, Mugford M. Cost-of-illness studies, elementary economic evaluation in health care. 2nd Ed., London: BMJ Publishing Group, 2000:17-29.
9. Haines, L., Wan, K., Lynn, R., Barrett, T. and Shield, J.  Rising incidence of type 2 diabetes in children in the UK. Diabetes Care 30: 1097–1101.
10. Vigersky RA. An overview of management issues in adult patients with type 2 diabetes mellitus. J Diabetes Sci Technol. 2011; 5: 245–250.
11. Brinsmead R : Use of Pharmacoeconomics in prescribing research. J Clin PharmTher 28:339-46.
12. Doubilet P, Weinstein MC, McNeil BJ : Use and misuse of the term “cost effective” in medicine. New Eng J Med, 314:253-6.
13. Drummond MF, Richardson SW : Users’ Guides to the Medical Literature. How to Use an Article on Economic Analysis of Clinical Practice. 277:1552-7.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.